Advertisement

Screening for asymptomatic carotid stenosis in patients with non-valvular atrial fibrillation

Published:November 23, 2022DOI:https://doi.org/10.1016/j.ijcard.2022.11.037
      Jolobe supports that screening for asymptomatic carotid stenosis (AsxCS) should be extended to patients with non-valvular atrial fibrillation (NVAF) [
      • Jolobe O.M.P.
      Screening for high-grade asymptomatic carotid artery stenosis in nonvalvular atrial fibrillation.
      ]. Indeed, a 2021 meta-analysis (n = 20 studies; 49,070 patients) demonstrated that the pooled prevalence of >50% AsxCS in patients with NVAF was 12.4% (range: 4.4–24.3%) [
      • Noubiap J.J.
      • Agbaedeng T.A.
      • Tochie J.N.
      • et al.
      Meta-analysis comparing the frequency of carotid artery stenosis in patients with atrial fibrillation and vice versa.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jolobe O.M.P.
        Screening for high-grade asymptomatic carotid artery stenosis in nonvalvular atrial fibrillation.
        Int. J. Cardiol. 2022 Nov 4; (S0167-5273(22)01691-6, In press)https://doi.org/10.1016/j.ijcard.2022.11.004
        • Noubiap J.J.
        • Agbaedeng T.A.
        • Tochie J.N.
        • et al.
        Meta-analysis comparing the frequency of carotid artery stenosis in patients with atrial fibrillation and vice versa.
        Am. J. Cardiol. 2021; 13: 72-79
        • Paraskevas K.I.
        • Spence J.D.
        • Mikhailidis D.P.
        • et al.
        Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A plea for a randomized controlled trial.
        Int. J. Cardiol. 2022; S0167-5273 (Online ahead of print): 01394-01398https://doi.org/10.1016/j.ijcard.2022.09.045
        • Naylor A.R.
        • Rantner B.
        • Ancetti S.
        • et al.
        European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the management of atherosclerotic carotid and vertebral artery disease.
        Eur. J. Vasc. Endovasc. Surg. 2022; S0178-5884 (00237–4. (Online ahead of print))https://doi.org/10.1016/j.ejvs.2022.04.011